Our latest articles
Keep up to date on all things OUTBREAK and antimicrobial resistance with our regular blog updates and media releases.
“It’s everywhere”. In one sentence, OUTBREAK co-founder and managing director A/Prof Branwen Morgan highlighted a key reason that tackling antimicrobial resistance (AMR) is so complex. Joining Caroline Duell, Andrew Bowskill and OUTBREAK’s Prof Antoine van Oijen for...
One of the world’s most common infections will cost Australia more than $1 billion a year within the next decade, if nothing is done to stop the rise of antibiotic resistant bacteria (superbugs). Analysis by national consortium, OUTBREAK, highlights how urinary tract...
Australian researchers are calling for more investment in finding out when, where and how current antibiotic treatments are working, as drug-resistant bacteria (superbugs) continue to spread globally. With governments and industry uniting to incentivise the...
OUTBREAK has adopted a high-performance, highly-flexible approach to turning masses of data into useful products and services to address drug-resistant infections. It’s a new way of working for a multi-agency team that’s on the hunt for information to improve health outcomes.
What do shopping centres, waterways and the jobless rate have in common? Well, if you combine them with local health data, you can start to map and predict the risk of antibiotic-resistance across Australia.
A big hurdle in the fight against antimicrobial resistance is helping Australians to understand how extensive the problem is for the whole population, not just sick people.
OUTBREAK is a significant opportunity for Australia to lead the global knowledge economy, according to Mimesis Technology’s chief data scientist.
The success of OUTBREAK would put Australia at the forefront of using machine learning to fight antimicrobial resistance.
As Asia-Pacific healthcare advisor for Oracle, Peter Williams has a keen interest in the junction between health, education and the research sector. Here he explains the multinational tech company’s involvement with OUTBREAK…
Developing the right tools to fight Antimicrobial Resistance in Australia will use insights from the largest cohort study in the Southern Hemisphere.
OUTBREAK industry partner Microba is a Brisbane-based biotech company that specialises in analysing microbial genomics, specifically – gut bacteria. Dr Ken McGrath is Microba’s Technology Liaison Manager…
OUTBREAK’s expert team spans many sectors, including the hospital system. For UTS Professor of Nursing Marilyn Cruickshank, the battle against Antimicrobial Resistance (AMR) has taken her from the ward to the policy table.
Professor Mitch Byrne leads the social and behavioural team within OUTBREAK’s Ethical, Legal and Social Implications stream. The team’s focus is on developing and maintaining community acceptance and a social licence for OUTBREAK to operate.
Australian pharmacists are in the box seat to play a major role in the fight against antibiotic-resistant superbugs, according to Dr Lisa Pont who is leading the Prescribing and Health Outcomes stream for OUTBREAK.
OUTBREAK CEO Branwen Morgan talks to Linda Mottram, the host of ABC Radio’s national PM program, about the rise of drug-resistant superbugs.
With predictions that drug-resistant superbugs’ could cause up to 10 million deaths a year by 2050, a new CSIRO survey has revealed a low level of community knowledge about antibiotics. The rise of superbugs, which claimed the lives of an estimated 700,000 people...
OUTBREAK’s Chief Technology Officer, Ian Pridham, explains the process of developing a world-first AI system with many complexities and potential users.
While most of us just flush and forget, what goes down our toilets and drains could be key to stopping a looming health and financial crisis in Australia from antibiotic resistant bacteria.
The OUTBREAK platform takes a world-leading AI approach to predicting the threat of an antibiotic resistant infection. Cloud and Data Management Lead Denis Bauer explains the novel approach to gathering and analysing data from humans, animals and the environment.
OUTBREAK CEO Branwen Morgan on SKY NEWS, discussing the link between COVID-19 and superbugs, and the benefits of developing an intelligent system to track, trace and tackle antibiotic resistance.
As Australia grapples with the economic fallout of COVID-19, an even bigger financial disaster is on the horizon, with drug-resistant bacteria set to cost the nation up to $283 billion by 2050.
Coronavirus shows how an infection can create global disruption. But a more deadly threat is already with us.
On August 21, 2019 Minister Hunt officially launched the OUTBREAK project saying:” The threat of antimicrobial resistance (AMR) fundamentally changes our approach to life.”
Antibiotics. They’ve been our go-to for treating (and sometimes preventing) bacterial infections ever since Alexander Fleming found mould keeping bacteria in check in his petri dishes almost a century ago and figured it was worth investigating.
UTS will lead a pioneering multi-institutional One Health initiative to address antimicrobial resistance. The project has secured a $1 million grant to develop an AI-powered network for surveillance and mitigation of antimicrobial resistance.
For more on antimicrobial resistance
Learn more about antimicrobial resistance and One Health by checking out these short clips below.
Saving our antibiotics with One Health
How we can stop superbugs and save our world